Delivery Order SPE2DB24D1034-SPE2DB25FWAX4

Award Date 3/3/25
Potential Completion Date 3/4/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,577.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/mL SureClick medication, a cardiovascular treatment. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $3,155.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha (140 mg/ml) SureClick, a specialty medication used for cardiovascular health. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,122.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Repatha 140 mg/ml SureClick, a specialty medication used in the treatment of cardiovascular health conditions. The contract has an ultimate completion date of February 10, 2025 and a firm fixed price pricing structure. This contract award is...
This federal contract award, valued at $43,022.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and covers the supply of Repatha 140 mg/ml SureClick medication. The award appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $19,652.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml SureClick medication, a specialty pharmaceutical product used to treat cardiovascular conditions. The award is a delivery order under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $2,103.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/mL SureClick, a specialty medication used for cardiovascular health. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $4,389.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a specialty medication used for cardiovascular health, with a delivery order completion date of December 13, 2024. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $14,990.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha 140 mg/ml SureClick medication, a specialty pharmaceutical product used for cardiovascular health. This is a delivery order contract with a firm-fixed price pricing type, and the ultimate completion date is November 12, 2024. The contract award is not...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,913.64 firm fixed-price contract is for the supply of Repatha 140 mg/ml SureClick (a specialty medication used to treat cardiovascular disease) to support federal healthcare programs, particularly military treatment facilities and veterans' healthcare systems. The award is part of a larger...
This federal contract award, valued at $11,030.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Repatha 140 mg/mL SureClick, a specialty medication used for cardiovascular health. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWAX4
    Delivery Order

This federal contract award, valued at $1,837.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml SureClick, a specialty medication used for cardiovascular health.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/2/25, 9:46 AM